![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novacyt’s Direct-to-PCR COVID-19 Test Approved in the UK
Novacyt’s Direct-to-PCR COVID-19 Test Approved in the UK
Novacyt said its PROmate COVID-19 2G polymerase chain-reaction (PCR) test has been approved for use in the UK.
The Anglo-French company, which has offices in Camberley, UK, and Paris, France, received UK approval for another real-time PCR test, COVID-19 genesig, in November 2021.
The PROmate test can detect two different SARS-CoV-2 genetic targets. The new test responds to the increased demand for multi-gene testing solutions that can identify multiple variants of the SARS-CoV-2 virus, the company said.
Novacyt said the new test is suitable for use in travel, sport, film, media and workplace settings.
Upcoming Events
-
21Oct